Comparative analysis of immunophenotypic methods for the assessment of minimal residual disease in hairy cell leukemia

Haematologica

Volumn 85, Issue 11, 2000, Pages 1227-1229

  Bengio, R ^a   Narbaitz, M I ^a   Sarmiento, M A ^a   Palacios, M F ^a   Scolnik, M P ^a  

^a INST DE INVEST HEMATOLOGICAS   (Argentina)

Author keywords

Flow cytometry; Immunohistochemistry; MRD in hairy cell leukemia

Indexed keywords

ARTICLE; CLINICAL ARTICLE; FLOW CYTOMETRY; HAIRY CELL LEUKEMIA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MINIMAL RESIDUAL DISEASE; RELAPSE;

FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LEUKEMIA, HAIRY CELL; NEOPLASM, RESIDUAL; REMISSION INDUCTION;

EID: 0033658585     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Minimal residual disease may predict bone marrow relapse in patients with hairy cell leukemia treated with 2-chlorodeoxyadenosine
2. Detection of minimal residual disease by inmmunostaining of bone marrow biopsies after 2-chlorodeoxyadenosine for hairy cell leukemia
3. The significance of minimal residual disease in hairy cell leukemia treated with deoxycoformycin: A long-term follow-up study
4. Immunomorphologic analysis of bone marrow biopsies after treatment with 2-chlorodeoxyadenosine for hairy cell leukemia
5. Minimal residual disease in hairy-cell leukemia after treatment with 2-chlorodeoxyadenosine
6. Minimal residual disease (MRD) in hairy cell leukemia (HCL): Comparative detection by flow cytometry (FC) and immunohistochemistry (IHC)
7. Remission in hairy cell leukemia with pentostatin
8. Minimal residual disease in patients with hairy cell leukemia in complete remission treated with 2-chlorodeoxyadenosine or 2-deoxycoformycin and prediction of early relapse